| Title | Author(s) | Issue date | ???itemlist.??? |
| Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival | Puduvalli, V. K.; Hashmi, M.; McAllister, L. D.; Levin, V. A.; Hess, K. R.; Prados, M.; Jaeckle, K. A.; Yung, W. K.; Buys, S. S.; Bruner, J. M.; Townsend, J. J.; Davis, R.; Sawaya, R.; Kyritsis, A. P. | 24-Nov-2015 | - |
| Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas | Kyritsis, A. P.; Yung, W. K.; Jaeckle, K. A.; Bruner, J.; Gleason, M. J.; Ictech, S. E.; Flowers, A.; Levin, V. A. | 24-Nov-2015 | - |
| Correlation between dynamic MRI and outcome in patients with malignant gliomas | Wong, E. T.; Jackson, E. F.; Hess, K. R.; Schomer, D. F.; Hazle, J. D.; Kyritsis, A. P.; Jaeckle, K. A.; Yung, W. K.; Levin, V. A.; Leeds, N. E. | 24-Nov-2015 | - |
| Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials | Wong, E. T.; Hess, K. R.; Gleason, M. J.; Jaeckle, K. A.; Kyritsis, A. P.; Prados, M. D.; Levin, V. A.; Yung, W. K. | 24-Nov-2015 | - |
| A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme | Groves, M. D.; Maor, M. H.; Meyers, C.; Kyritsis, A. P.; Jaeckle, K. A.; Yung, W. K.; Sawaya, R. E.; Hess, K.; Bruner, J. M.; Peterson, P.; Levin, V. A. | 24-Nov-2015 | - |
| Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme | Levin, V. A.; Uhm, J. H.; Jaeckle, K. A.; Choucair, A.; Flynn, P. J.; Yung, W. K. A.; Prados, M. D.; Bruner, J. M.; Chang, S. M.; Kyritsis, A. P.; Gleason, M. J.; Hess, K. R. | 24-Nov-2015 | - |
| Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas | Levin, V. A.; Hess, K. R.; Choucair, A.; Flynn, P. J.; Jaeckle, K. A.; Kyritsis, A. P.; Yung, W. K.; Prados, M. D.; Bruner, J. M.; Ictech, S.; Gleason, M. J.; Kim, H. W. | 24-Nov-2015 | - |
| Response and progression in recurrent malignant glioma | Hess, K. R.; Wong, E. T.; Jaeckle, K. A.; Kyritsis, A. P.; Levin, V. A.; Prados, M. D.; Yung, W. K. | 24-Nov-2015 | - |
| TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors | Kaba, S. E.; Kyritsis, A. P.; Hess, K.; Yung, W. K.; Mercier, R.; Dakhil, S.; Jaeckle, K. A.; Levin, V. A. | 24-Nov-2015 | - |
| The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B | Kaba, S. E.; DeMonte, F.; Bruner, J. M.; Kyritsis, A. P.; Jaeckle, K. A.; Levin, V.; Yung, W. K. | 24-Nov-2015 | - |
